Literature DB >> 27574773

Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.

Young Chan Lee1, Se Young Na1, Gi Cheol Park2, Ju Hyun Han2, Seung Woo Kim3, Young Gyu Eun4.   

Abstract

BACKGROUND: The impact of occult lymph node metastasis on regional recurrence after prophylactic central neck dissection for preoperative, nodal-negative papillary thyroid cancer is controversial. We investigated risk factors for regional lymph node recurrence in papillary thyroid cancer patients who underwent total thyroidectomy and bilateral prophylactic central neck dissection. Analysis was according to clinicopathologic characteristics and occult lymph node metastasis patterns.
METHODS: This multicenter study enrolled 211 consecutive patients who underwent total thyroidectomy with bilateral prophylactic central neck dissection for papillary thyroid cancer without evidence of central lymph node metastasis on preoperative imaging. Clinicopathologic features and central lymph node metastasis patterns were analyzed for predicting regional recurrence. Multivariate Cox regression analysis was used to identify independent factors for recurrence.
RESULTS: Median follow-up time was 43 months (24-95 months). Ten patients (4.7%) showed regional lymph node recurrence. The estimated 5-year, regional recurrence-free survival was 95.2%. Tumor size ≥1 cm, central lymph node metastasis, lymph node ratio, and prelaryngeal lymph node metastasis were associated with regional recurrence in univariate analysis (P < .05). In multivariate analysis, a lymph node ratio ≥ 0.26 was a significant risk factor for regional lymph node recurrence (odds ratio = 11.63, P = .003). Lymph node ratio ≥ 0.26 was an independent predictor of worse recurrence-free survival on Cox regression analysis (hazard ratio = 11.49, P = .002).
CONCLUSION: Although no significant association was observed between the presence of occult lymph node metastasis and regional recurrence, lymph node ratio ≥ 0.26 was an independent predictor of regional lymph node recurrence in papillary thyroid cancer patients who underwent total thyroidectomy and bilateral prophylactic central neck dissection.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27574773     DOI: 10.1016/j.surg.2016.07.031

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  24 in total

1.  Limitation of intraoperative frozen section during thyroid surgery.

Authors:  Sandrine Estebe; Cecile Montenat; Adrien Tremoureux; Chloé Rousseau; François Bouilloud; Franck Jegoux
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-02       Impact factor: 2.503

Review 2.  Sentinel lymph node biopsy in small papillary thyroid cancer. A review on novel surgical techniques.

Authors:  Ludovico Maria Garau; Domenico Rubello; Alice Ferretti; Giuseppe Boni; Duccio Volterrani; Gianpiero Manca
Journal:  Endocrine       Date:  2018-07-02       Impact factor: 3.633

3.  Risk factors for high-volume lymph node metastases in cN0 papillary thyroid microcarcinoma.

Authors:  Chunhao Liu; Yuewu Liu; Lei Zhang; Yunwei Dong; Shenbao Hu; Yu Xia; Bo Zhang; Yue Cao; Ziwen Liu; Ge Chen; Zhonghua Shang; Jinbao Yang; Qinghe Sun; Xiaoyi Li
Journal:  Gland Surg       Date:  2019-10

4.  Prediction of level V metastases in papillary thyroid microcarcinoma: a single center analysis.

Authors:  Wenlong Wang; Ning Bai; Qianhui Ouyang; Botao Sun; Chong Shen; Xinying Li
Journal:  Gland Surg       Date:  2020-08

5.  Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.

Authors:  Chuan-Ming Zheng; Yong Bae Ji; Chang Myeon Song; Ming-Hua Ge; Kyung Tae
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-10-17       Impact factor: 3.372

6.  Regional Node Distribution in Papillary Thyroid Cancer with Microscopic Metastasis.

Authors:  Luis-Mauricio Hurtado-López; Alejandro Ordoñez-Rueda; Felipe-Rafael Zaldivar-Ramírez; Erich Basurto-Kuba
Journal:  J Thyroid Res       Date:  2018-11-01

7.  Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma.

Authors:  Yi-Li Zhou; Chen Zheng; Yi-Tong Chen; Xue-Min Chen
Journal:  Onco Targets Ther       Date:  2018-11-01       Impact factor: 4.147

8.  Predictive Factors of Recurrence in Patients with Differentiated Thyroid Carcinoma: A Retrospective Analysis on 579 Patients.

Authors:  Fabio Medas; Gian Luigi Canu; Francesco Boi; Maria Letizia Lai; Enrico Erdas; Pietro Giorgio Calò
Journal:  Cancers (Basel)       Date:  2019-08-22       Impact factor: 6.639

9.  Long noncoding RNA LINC00284 facilitates cell proliferation in papillary thyroid cancer via impairing miR-3127-5p targeted E2F7 suppression.

Authors:  Bin Zhou; Yugang Ge; Qing Shao; Liyi Yang; Xin Chen; Guoqin Jiang
Journal:  Cell Death Discov       Date:  2021-06-26

10.  A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma.

Authors:  Zhou-Ci Zheng; Qing-Xuan Wang; Wei Zhang; Xiao-Hua Zhang; Du-Ping Huang
Journal:  Onco Targets Ther       Date:  2018-01-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.